AMGN R&D Expenses

Amgen · R&D Expenses

AMGN logo

AMGN R&D Expenses

Latest reported$7.64B
AMGN TTM R&D Expenses ($0.00 → $7.64B)
High-resolution chart · PNG

AMGN r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Amgen R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
7,638,000,000
7,514,000,000
7,281,000,000
6,854,000,000
6,404,000,000
6,107,000,000
5,964,000,000
5,774,000,000
5,403,000,000
5,069,000,000
4,784,000,000
4,574,000,000
4,607,000,000
4,533,000,000
4,434,000,000
4,458,000,000
4,768,000,000
4,811,000,000
4,819,000,000
4,700,000,000
4,340,000,000
4,222,000,000
4,207,000,000
4,290,000,000
4,229,000,000
4,189,000,000
4,116,000,000
3,986,000,000
3,911,000,000
3,856,000,000
3,737,000,000
3,598,000,000
3,549,000,000
3,553,000,000
3,562,000,000
3,597,000,000
3,710,000,000
3,737,000,000
3,840,000,000
3,855,000,000
3,984,000,000
4,048,000,000
4,070,000,000
4,211,000,000
4,110,000,000
4,164,000,000
4,297,000,000
4,312,000,000
4,283,000,000
4,232,000,000
4,083,000,000
3,772,000,000
3,663,000,000
3,522,000,000
3,380,000,000
3,293,000,000
3,174,000,000
3,167,000,000
3,167,000,000
3,170,000,000
3,128,000,000
2,984,000,000
2,894,000,000
2,931,000,000
2,859,000,000
2,877,000,000
2,864,000,000
2,771,000,000
2,853,000,000
2,969,000,000
3,030,000,000
3,054,000,000
3,101,000,000
3,109,000,000
3,266,000,000
3,495,000,000
3,591,000,000
3,562,000,000
3,366,000,000
2,976,000,000
2,666,000,000
2,445,000,000
2,314,000,000
2,270,000,000
2,210,000,000
2,111,000,000
2,028,000,000
1,913,900,000
1,819,900,000
1,745,600,000
1,655,900,000
1,520,000,000
1,424,600,000
1,264,500,000
1,116,600,000
982,200,000
886,500,000
861,700,000
865,000,000
881,900,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.